Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease.

CONCLUSION: ULT significantly delayed renal disease progression in hyperuricemic patients with CKD. Goal-directed ULT seems to be better than continuing the initial ULT prescription. PMID: 26428209 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26428209?dopt=Abstract

Source: J Rheumatol - October 1, 2015 Category: Rheumatology Authors: Kim Y, Shin S, Kim K, Choi S, Lee K Tags: J Rheumatol Source Type: research

More News: Chronic Kidney Disease | Dialysis | Hospital Management | Rheumatology | Urology & Nephrology